Aphtostomatitis and Mucositis Treatment by Natural Herbal Formula (Sorend®)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2011 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
Sponsor:
Collaborator:
R&T Health Products Ltd.
Information provided by:
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT01321307
First received: March 22, 2011
Last updated: NA
Last verified: March 2011
History: No changes posted

March 22, 2011
March 22, 2011
April 2011
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Aphtostomatitis and Mucositis Treatment by Natural Herbal Formula (Sorend®)
Aphtostomatitis and Mucositis Treatment by Natural Herbal Formula (Sorend®)
Sorend is a water-based formula, which contains carob, melissa and sage. Elder inhabitants of Israel are known to use carob extract to ease sores in the mouth, due to the tannins which create a complex with various proteins and polysaccharides, thus creating an impenetrable layer covering the sores, allowing spontaneous healing.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Community population care
  • Aphtostomatitis
  • Mucositis
Not Provided
  • Sorend
    Group no. 1 shall receive Sorend following diagnosis of aphtostomatitis or mucositis.
  • Sorend placebo
    Group no. 2 shall receive Sorend placebo following diagnosis of aphtostomatitis or mucositis.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
120
Not Provided
Not Provided

Inclusion Criteria:

  • Herpetic aphtomatitis
  • Bacterial aphtostomatitis
  • Viral aphtostomatitis
  • Fungal aphtostomatitis

Exclusion Criteria:

  • Oncology patients
  • Systematic diseases (Colitis, Crohn, diabetes, Behcet)
  • Pregnancy
  • Arthritis
Sexes Eligible for Study: All
18 Years to 70 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT01321307
91-2010-HYMC
No
Not Provided
Not Provided
Not Provided
Galit Avior, MD, Hillel Yaffe Medical Center
Hillel Yaffe Medical Center
R&T Health Products Ltd.
Principal Investigator: Galit Avior, MD Hillel Yaffe Medical Center, Hadera, Israel
Hillel Yaffe Medical Center
March 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP